IMPLICON: an ultra-deep sequencing method to uncover DNA methylation at imprinted regions.


Journal

Nucleic acids research
ISSN: 1362-4962
Titre abrégé: Nucleic Acids Res
Pays: England
ID NLM: 0411011

Informations de publication

Date de publication:
18 09 2020
Historique:
accepted: 02 07 2020
revised: 16 06 2020
received: 21 03 2020
pubmed: 6 7 2020
medline: 29 10 2020
entrez: 5 7 2020
Statut: ppublish

Résumé

Genomic imprinting is an epigenetic phenomenon leading to parental allele-specific expression. Dosage of imprinted genes is crucial for normal development and its dysregulation accounts for several human disorders. This unusual expression pattern is mostly dictated by differences in DNA methylation between parental alleles at specific regulatory elements known as imprinting control regions (ICRs). Although several approaches can be used for methylation inspection, we lack an easy and cost-effective method to simultaneously measure DNA methylation at multiple imprinted regions. Here, we present IMPLICON, a high-throughput method measuring DNA methylation levels at imprinted regions with base-pair resolution and over 1000-fold coverage. We adapted amplicon bisulfite-sequencing protocols to design IMPLICON for ICRs in adult tissues of inbred mice, validating it in hybrid mice from reciprocal crosses for which we could discriminate methylation profiles in the two parental alleles. Lastly, we developed a human version of IMPLICON and detected imprinting errors in embryonic and induced pluripotent stem cells. We also provide rules and guidelines to adapt this method for investigating the DNA methylation landscape of any set of genomic regions. In summary, IMPLICON is a rapid, cost-effective and scalable method, which could become the gold standard in both imprinting research and diagnostics.

Identifiants

pubmed: 32621604
pii: 5867412
doi: 10.1093/nar/gkaa567
pmc: PMC7498334
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e92

Subventions

Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/T009713/1
Pays : United Kingdom

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of Nucleic Acids Research.

Références

Nature. 1991 Jan 3;349(6304):84-7
pubmed: 1845916
PLoS Genet. 2014 Dec 11;10(12):e1004868
pubmed: 25501653
Stem Cell Reports. 2013 Jun 04;1(1):79-89
pubmed: 24052944
Genome Biol. 2019 Dec 12;20(1):272
pubmed: 31831055
Cell. 1984 May;37(1):179-83
pubmed: 6722870
Nature. 2009 Nov 19;462(7271):315-22
pubmed: 19829295
Annu Rev Genomics Hum Genet. 2014;15:93-126
pubmed: 24898037
Stem Cell Reports. 2019 Oct 8;13(4):761-774
pubmed: 31564644
Cell. 1991 Feb 22;64(4):849-59
pubmed: 1997210
Trends Genet. 2018 Sep;34(9):666-681
pubmed: 29941292
Cell Rep. 2016 Sep 27;17(1):179-192
pubmed: 27681430
Development. 2017 Aug 1;144(15):2748-2763
pubmed: 28765214
Cell. 2019 Feb 21;176(5):952-965
pubmed: 30794780
Cell Stem Cell. 2012 May 4;10(5):620-34
pubmed: 22560082
Cell. 2012 Feb 17;148(4):816-31
pubmed: 22341451
Bioinformatics. 2002 Nov;18(11):1427-31
pubmed: 12424112
Nature. 2014 Jul 10;511(7508):177-83
pubmed: 25008523
Nat Rev Genet. 2014 Aug;15(8):517-30
pubmed: 24958438
Methods Mol Biol. 2018;1767:351-366
pubmed: 29524145
Curr Opin Genet Dev. 2017 Apr;43:101-109
pubmed: 28260631
Nat Biotechnol. 2019 Apr;37(4):424-429
pubmed: 30804537
Am J Physiol Regul Integr Comp Physiol. 2008 Jul;295(1):R189-96
pubmed: 18448610
Nature. 1984 Apr 5-11;308(5959):548-50
pubmed: 6709062
Nature. 1985 Jun 6-12;315(6019):496-8
pubmed: 4000278
Neurotherapeutics. 2015 Jul;12(3):641-50
pubmed: 26040994
PLoS Genet. 2012;8(4):e1002605
pubmed: 22511876
Nucleic Acids Res. 2005 Jan 13;33(1):e9
pubmed: 15653630
Proc Natl Acad Sci U S A. 1992 Mar 1;89(5):1827-31
pubmed: 1542678
Nature. 2008 Aug 7;454(7205):766-70
pubmed: 18600261
G3 (Bethesda). 2018 Jan 4;8(1):91-103
pubmed: 29138238
Nature. 1991 May 9;351(6322):153-5
pubmed: 1709450
Cell Rep. 2017 May 2;19(5):957-968
pubmed: 28467909
EMBO J. 2019 Jun 17;38(12):
pubmed: 31088843
Nat Genet. 2003 Sep;35(1):97-102
pubmed: 12937418
Genes Dev. 2001 Sep 15;15(18):2361-6
pubmed: 11562346
Stem Cell Reports. 2016 Apr 12;6(4):437-446
pubmed: 26947977
Hum Mol Genet. 2018 Dec 1;27(23):3999-4011
pubmed: 30102380
Genome Biol. 2017 Apr 11;18(1):68
pubmed: 28399939
Science. 2010 Aug 6;329(5992):643-8
pubmed: 20616232
Cell Stem Cell. 2016 Mar 3;18(3):323-329
pubmed: 26853856
Epigenomics. 2018 Jul;10(7):941-954
pubmed: 29962238
Clin Genet. 2017 Jan;91(1):3-13
pubmed: 27363536
Cell. 2014 Sep 11;158(6):1254-1269
pubmed: 25215486
Nat Rev Genet. 2019 Apr;20(4):235-248
pubmed: 30647469
PLoS Genet. 2019 Jun 20;15(6):e1008151
pubmed: 31220079
Genes Dev. 2019 Jan 1;33(1-2):49-54
pubmed: 30602440
Cell Rep. 2019 Jan 22;26(4):815-824.e4
pubmed: 30673604
Dev Cell. 2008 Oct;15(4):547-57
pubmed: 18854139
Genome Biol. 2020 Mar 3;21(1):54
pubmed: 32127008
Genet Med. 2012 Jan;14(1):10-26
pubmed: 22237428
Nat Biotechnol. 2008 Jul;26(7):779-85
pubmed: 18612301
Nucleic Acids Res. 2019 May 7;47(8):e46
pubmed: 30793194
Novartis Found Symp. 1998;214:251-9; discussion 260-3
pubmed: 9601022
Nat Protoc. 2007;2(9):2265-75
pubmed: 17853883
Nature. 1991 Jun 20;351(6328):667-70
pubmed: 2052093
Bioinformatics. 2011 Jun 1;27(11):1571-2
pubmed: 21493656
Mol Cell. 2012 Sep 28;47(6):909-20
pubmed: 22902559

Auteurs

Tajda Klobučar (T)

Instituto de Medicina Molecular, João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisboa, Portugal.

Elisa Kreibich (E)

Epigenetics Programme, Babraham Institute, Cambridge CB22 3AT, UK.

Felix Krueger (F)

Bioinformatics Group, Babraham Institute, Cambridge CB22 3AT, UK.

Maria Arez (M)

Instituto de Medicina Molecular, João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisboa, Portugal.

Duarte Pólvora-Brandão (D)

Instituto de Medicina Molecular, João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisboa, Portugal.

Ferdinand von Meyenn (F)

Epigenetics Programme, Babraham Institute, Cambridge CB22 3AT, UK.

Simão Teixeira da Rocha (ST)

Instituto de Medicina Molecular, João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisboa, Portugal.

Melanie Eckersley-Maslin (M)

Epigenetics Programme, Babraham Institute, Cambridge CB22 3AT, UK.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH